Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|November 26, 1988
Nasopharyngeal oxygen in childrenF Shann, S Gatchalian, R Hutchinson
The Southeast Asian Journal of Tropical Medicine and Public Health|October 22, 2009
Reactogenicity and immunogenicity of a live-attenuated refrigerator-stable varicella vaccine (OKA strain) in healthy seronegative subjects age 10 months to 12 yearsS R H Hadinegoro, I S Hindra, H H Han, et al.
The American Journal of Tropical Medicine and Hygiene|August 31, 1999
Reliability of parental history of antibiotic use for Filipino children admitted with acute lower respiratory tract infectionL Sombrero, M E Sunico, B Quiambao, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 25, 2000
A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of ageS Gatchalian, L Cordero-Yap, M Lu-Fong, et al.
The Southeast Asian Journal of Tropical Medicine and Public Health|April 20, 2000
The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birthL Bravo, J Carlos, S Gatchalian, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 6, 2007
The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine componentsS Gatchalian, E Palestroque, I De Vleeschauwer, et al.
Statistics in Medicine|May 22, 1998
Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study GroupF E Harrell, P A Margolis, S Gove, et al.
Vaccine|January 25, 2011
Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007D D Anh, C C Carlos, D V Thiem, et al.
Pageof 1